Skip to content
value.today

Otonomy, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2008
Total raised
$35 M
2 rounds on record
Latest round
$24 M
Aug 2010
First round on record
May 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Otonomy, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2010$24 MNo. 2$10 to $50 million

Otonomy, Inc.: Raise no. 2, Aug 2010

Investors in this round

13 investors had bought by the notice of Jun 2, 2011: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Otonomy, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$24 M of $39 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carl LeBel · Executive Officer
  • David Weber · Executive Officer, Director
  • Gerald Wroblewski · Executive Officer
  • Paul Cayer · Executive Officer
  • Brian Dovey · Director
  • Heather Preston · Director
  • Jay Lichter · Director
  • Jeffrey Harris · Director
  • John McKearn · Director
  • Peter Bisgaard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$14,125,289.53 previously sold on May 18, 2011”

Signed by David Weber, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 2, 2011. Read the notice at the SEC.

equitySEC
May 2010$11 MNo. 1$10 to $50 million

Otonomy, Inc.: Raise no. 1, May 2010

Investors in this round

3 investors had bought by the notice of Jun 9, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Otonomy, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $26 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carl LeBel, Ph.D. · Executive Officer
  • Douglas Downs · Executive Officer
  • Jay Lichter, Ph.D. · Executive Officer, Director
  • Paul Cayer · Executive Officer
  • Court Turner · Director
  • Jeffrey Harris, M.D., Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jay Lichter, Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 9, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Otonomy, Inc. had no revenue when it filed its newest notice of a funding round (Jun 2011).

    SEC Form D (revenue range) · Jun 2011

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2011

Products and services#

No products or services on record: its website did not answer.

Investors#

9 named in official filings. Open an investor to see everything it has backed.

Investors in Otonomy, Inc.
InvestorKindAmountRoundRoleSource
Avalon Ventures VIII LPVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Avalon Ventures X, L.P.Venture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Domain Partners VIII, L.P.Fund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
DP VIII Associates, L.P.Fund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Novo Holdings A/sFund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
OrbiMed Capital GP IV LLCFund or asset managernot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
TPG Group Holdings (SBS) Advisors, Inc.Fund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Vickie L. CappsPersonnot statednot statedHeld Series D preferred stock, director (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Otonomy, Inc.
NameRoleNamed in
Carl LeBelExecutive officerJun 2011
David WeberExecutive officerJun 2011
Gerald WroblewskiExecutive officerJun 2011
Paul CayerExecutive officerJun 2011
Court TurnerExecutive officerSep 2010
Douglas DownsExecutive officerSep 2010
Jay Lichter, Ph.D.Executive officerSep 2010
Carl LeBel, Ph.D.Executive officerJun 2010
Brian DoveyDirectorJun 2011
David WeberDirectorJun 2011
Heather PrestonDirectorJun 2011
Jay LichterDirectorJun 2011
Jeffrey HarrisDirectorJun 2011
John McKearnDirectorJun 2011
Peter BisgaardDirectorJun 2011
Jay Lichter, Ph.D.DirectorSep 2010
Jeffrey Harris, M.D., Ph.D.DirectorSep 2010
Court TurnerDirectorJun 2010

About

Company in San Diego, United States.